Hepatocellular Carcinoma Tumor Thrombus Entering the Right Atrium Treated with Combining Percutaneous and Intravenous High-dose-rate Brachytherapy: a Case Report

Overview

Journal CVIR Endovasc

Date 2021 Oct 7

PMID 34618268

Citations 2

Authors

F N Fleckenstein

M Jonczyk

E Can

W M Ludemann

L Savic

T Maleitzke

F Krenzien

B Gebauer

Affiliations

Soon will be listed here.

Abstract

The presented report describes a case of a Hepatocellular carcinoma (HCC) tumor thrombus (TT) infiltrating the inferior vena cava (IVC) and the right atrium (RA) in a 66-year old male patient who initially presented with TT related symptoms. CT-guided high-dose-rate brachytherapy (HDRBT) was performed for both, the intraparenchymal primary and the TT. A marked improvement of the tumor-related symptoms and shrinkage of the tumor mass were achieved six months after treatment initiation. The combination of intravascular and percutaneous HDRBT demonstrating a promising approach to palliate tumor-related symptoms in advanced HCC with macrovascular invasion.

Citing Articles

Surgical Treatment of Hepatocellular Carcinoma with a Tumor Thrombus Invading the Right Atrium: A Case Report.

Veinberga L, Meidrops K, Rumba R, Gedins M, Anufrijevs D, Vilmanis J Case Rep Oncol. 2023; 16(1):422-430.

PMID: 37384203 PMC: 10294241. DOI: 10.1159/000529831.

Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor Thrombus.

Qian Y, Gong L, Li S, Mao K, Li X, Liao G Front Oncol. 2022; 12:879454.

PMID: 35646629 PMC: 9133506. DOI: 10.3389/fonc.2022.879454.

References

Saynak M, Ozen A, Kocak Z, Cosar-Alas R, Uzal C . Sudden death: a case report of hepatocellular carcinoma with tumor thrombus extending into the right atrium. J BUON. 2007; 12(4):556. View

Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G . Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002; 89(10):1206-22. DOI: 10.1046/j.1365-2168.2002.02168.x. View

Sakamoto K, Nagano H . Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium. Surg Today. 2017; 48(9):819-824. DOI: 10.1007/s00595-017-1619-2. View

Pao T, Hsueh W, Chang W, Chiang N, Lin Y, Liu Y . Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer. 2019; 19(1):560. PMC: 6558860. DOI: 10.1186/s12885-019-5654-9. View

Ricke J, Wust P, Stohlmann A, Beck A, Cho C, Pech M . CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys. 2004; 58(5):1496-505. DOI: 10.1016/j.ijrobp.2003.09.024. View

Florman S, Weaver M, Primeaux P, Killackey M, Sierra R, Gomez S . Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg. 2009; 75(11):1104-8. View

Cornberg M, Tacke F, Karlsen T . Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability. J Hepatol. 2018; 70(1):5-7. DOI: 10.1016/j.jhep.2018.10.011. View

Collettini F, Schreiber N, Schnapauff D, Denecke T, Wust P, Schott E . CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma. Strahlenther Onkol. 2014; 191(5):405-12. DOI: 10.1007/s00066-014-0781-3. View

Giorgio A, Calisti G, Montesarchio L, Scognamiglio U, Matteucci P, Coppola C . Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study. Anticancer Res. 2014; 34(11):6785-90. View

10.

Gomes M, Priolli D, Tralhao J, Botelho M . Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies. Rev Assoc Med Bras (1992). 2013; 59(5):514-24. DOI: 10.1016/j.ramb.2013.03.005. View

11.

Brinkhaus G, Lock J, Malinowski M, Denecke T, Neuhaus P, Hamm B . CT-guided high-dose-rate brachytherapy of liver tumours does not impair hepatic function and shows high overall safety and favourable survival rates. Ann Surg Oncol. 2014; 21(13):4284-92. DOI: 10.1245/s10434-014-3835-y. View

12.

Li W, Wang Y, Gao W, Zheng J . HCC with tumor thrombus entering the right atrium and inferior vena cava treated by percutaneous ablation. BMC Surg. 2017; 17(1):21. PMC: 5331644. DOI: 10.1186/s12893-017-0217-y. View

13.

Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K . The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984; 54(7):1461-5. DOI: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7. View

14.

Giorgio A, Di Sarno A, de Stefano G, Farella N, Scognamiglio U, de Stefano M . Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?. AJR Am J Roentgenol. 2009; 193(4):948-54. DOI: 10.2214/AJR.08.2087. View

15.

Gatti P, Giorgio A, Ciraci E, Roberto I, Anglani A, Sergio S . Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report. J Ultrasound. 2019; 22(3):363-370. PMC: 6704268. DOI: 10.1007/s40477-019-00361-w. View